| name | ata-post-cushing-axis-retest |
| description | Retest thyroid and GH axes after curative surgery for Cushing's disease before initiating hormone replacement. Use when managing postoperative Cushing's disease patient; triggers include postoperative Cushing's surgery patient needing hormone reassessment. |
Retest thyroid and GH axes after Cushing's surgery before replacement
STEP 1 — Gather Information
Confirm curative resection of ACTH-secreting tumor, document postoperative timing, review baseline pituitary function, assess for symptoms of hypopituitarism, and verify no active glucocorticoid replacement that could suppress axis testing.
STEP 2 — Rule In / Rule Out
If curative surgery for Cushing's disease is confirmed and patient is in the postoperative period, proceed to axis retesting; otherwise, do not apply this skill and manage per standard postoperative care.
STEP 3 — Classify or Stratify
Classify as requiring evaluation of both thyroid (central hypothyroidism) and GH (adult GH deficiency) axes; order serum free T4 and TSH for thyroid assessment and a GH stimulation test (e.g., insulin tolerance, glucagon, or GHRH‑arginine) for GH deficiency.
STEP 4 — Decide
If free T4 is below reference range with non‑elevated TSH, start levothyroxine; if GH stimulation test shows subnormal peak GH per BMI‑adjusted cutoff, initiate GH replacement only after confirming adequate HPA axis recovery.
Clinical Guardrails / Mimics / Pitfalls
Do not start thyroid or GH replacement before confirming axis recovery; avoid assuming permanent dysfunction—transient postoperative suppression can mimic deficiency; ensure adequate glucocorticoid stress dosing is not mistaken for axis recovery; avoid over‑replacement by using symptom‑guided dosing.
Concrete Clinical Example
A 35‑year‑old woman underwent transsphenoidal resection of an ACTH‑secreting macroadenoma for Cushing's disease. Six weeks postoperatively she reports fatigue and mild weight gain. Before starting any replacement, her clinician orders fT4, TSH, and an insulin tolerance test for GH. Results show fT4 0.6 ng/dL (low), TSH 2.1 µIU/mL (normal), and GH peak 3.2 µg/L (below the BMI‑adjusted cutoff of 5 µg/L). Central hypothyroidism and GH deficiency are diagnosed; low‑dose levothyroxine and GH replacement are initiated after confirming morning cortisol > 18 µg/dL on off‑steroid testing.
Source: Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI: 10.1210/jc.2016-2118
